Healthcare Industry Reports

Reports > Healthcare > Selected Report

North America Transdermal Drug Delivery System Market Report for Period 2017 till 2022

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.


Scope of the Report
This report focuses on the Transdermal Drug Delivery System in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other

Market Segment by Applications, can be divided into
OTC
Rx

There are 15 Chapters to deeply display the North America Transdermal Drug Delivery System market.

Chapter 1, to describe Transdermal Drug Delivery System Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Transdermal Drug Delivery System, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Transdermal Drug Delivery System, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Transdermal Drug Delivery System market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Transdermal Drug Delivery System Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Transdermal Drug Delivery System Introduction
1.2 Market Analysis by Type
1.2.1 Fentanyl
1.2.2 Nitroglycerin
1.2.3 Estradiol
1.2.4 Nicotine
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 OTC
1.3.2 Rx
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hisamitsu
2.1.1 Profile
2.1.2 Transdermal Drug Delivery System Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Hisamitsu News
2.2 Mylan
2.2.1 Profile
2.2.2 Transdermal Drug Delivery System Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Mylan Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Mylan News
2.3 GSK
2.3.1 Profile
2.3.2 Transdermal Drug Delivery System Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 GSK Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 GSK News
2.4 Novartis
2.4.1 Profile
2.4.2 Transdermal Drug Delivery System Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Novartis Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Novartis News
2.5 Teve (Actavis)
2.5.1 Profile
2.5.2 Transdermal Drug Delivery System Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teve (Actavis) Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Teve (Actavis) News
2.6 Johnson & Johnson
2.6.1 Profile
2.6.2 Transdermal Drug Delivery System Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Johnson & Johnson News
2.7 Lohmann
2.7.1 Profile
2.7.2 Transdermal Drug Delivery System Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Lohmann Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Lohmann News
2.8 Teikoku Seiyaku
2.8.1 Profile
2.8.2 Transdermal Drug Delivery System Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Teikoku Seiyaku News
2.9 Bayer
2.9.1 Profile
2.9.2 Transdermal Drug Delivery System Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Bayer Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Bayer News
2.10 Lingrui
2.10.1 Profile
2.10.2 Transdermal Drug Delivery System Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Lingrui Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Lingrui News
2.11 Sanofi
2.11.1 Profile
2.11.2 Transdermal Drug Delivery System Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Sanofi Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Sanofi News
2.12 Qizheng
2.12.1 Profile
2.12.2 Transdermal Drug Delivery System Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Qizheng Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Qizheng News
2.13 Endo
2.13.1 Profile
2.13.2 Transdermal Drug Delivery System Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Endo Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Endo News
2.14 Huarun 999
2.14.1 Profile
2.14.2 Transdermal Drug Delivery System Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Huarun 999 Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Huarun 999 News
2.15 Haw Par
2.15.1 Profile
2.15.2 Transdermal Drug Delivery System Type and Applications
2.15.2.1 Type 1
.2.2 Type 2
2.15.3 Haw Par Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15.4 Business Overview
2.15.5 Haw Par News
2.16 Nichiban
2.16.1 Profile
2.16.2 Transdermal Drug Delivery System Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Nichiban Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16.4 Business Overview
2.16.5 Nichiban News
2.17 Mentholatum Company
2.17.1 Profile
2.17.2 Transdermal Drug Delivery System Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Mentholatum Company Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17.4 Business Overview
2.17.5 Mentholatum Company News
2.18 Laboratoires Genevrier
2.18.1 Profile
2.18.2 Transdermal Drug Delivery System Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18.4 Business Overview
2.18.5 Laboratoires Genevrier News
3 North America Transdermal Drug Delivery System Market Competition, by Manufacturer
3.1 North America Transdermal Drug Delivery System Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Transdermal Drug Delivery System Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Transdermal Drug Delivery System Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Drug Delivery System Manufacturer Market Share
3.4.2 Top 5 Transdermal Drug Delivery System Manufacturer Market Share
3.5 Market Competition Trend
4 North America Transdermal Drug Delivery System Market Analysis by Countries
4.1 North America Transdermal Drug Delivery System Sales Market Share by Countries
4.2 North America Transdermal Drug Delivery System Sales by Countries (2012-2017)
4.3 North America Transdermal Drug Delivery System Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Transdermal Drug Delivery System by Type
5.1 North America Transdermal Drug Delivery System Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Transdermal Drug Delivery System Sales and Market Share by Type (2012-2017)
5.1.2 North America Transdermal Drug Delivery System Revenue and Market Share by Type (2012-2017)
5.2 Fentanyl Sales Growth and Price
5.2.1 North America Fentanyl Sales Growth (2012-2017)
5.2.2 North America Fentanyl Price (2012-2017)
5.3 Nitroglycerin Sales Growth and Price
5.3.1 North America Nitroglycerin Sales Growth (2012-2017)
5.3.2 North America Nitroglycerin Price (2012-2017)
5.4 Estradiol Sales Growth and Price
5.4.1 North America Estradiol Sales Growth (2012-2017)
5.4.2 North America Estradiol Price (2012-2017)
5.5 Nicotine Sales Growth and Price
5.5.1 North America Nicotine Sales Growth (2012-2017)
5.5.2 North America Nicotine Price (2012-2017)
5.6 Other Sales Growth and Price
5.6.1 North America Other Sales Growth (2012-2017)
5.6.2 North America Other Price (2012-2017)
6 North America Market Segmentation Transdermal Drug Delivery System by Application
6.1 North America Transdermal Drug Delivery System Sales Market Share by Application (2012-2017)
6.2 OTC Sales Growth (2012-2017)
6.3 Rx Sales Growth (2012-2017)
7 United States Transdermal Drug Delivery System Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Transdermal Drug Delivery System Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Transdermal Drug Delivery System Sales and Market Share by Type
7.3 United States Transdermal Drug Delivery System Sales by Application (2012-2017)
7.4 United States Transdermal Drug Delivery System Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Transdermal Drug Delivery System Sales and Market Share by Manufacturer
7.4.2 United States Transdermal Drug Delivery System Revenue and Market Share by Manufacturer
7.5 United States Transdermal Drug Delivery System Export and Import (2012-2017)
8 Canada Transdermal Drug Delivery System Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Transdermal Drug Delivery System Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Transdermal Drug Delivery System Sales and Market Share by Type
8.3 Canada Transdermal Drug Delivery System Sales by Application (2012-2017)
8.4 Canada Transdermal Drug Delivery System Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Transdermal Drug Delivery System Sales and Market Share by Manufacturer
8.4.2 Canada Transdermal Drug Delivery System Revenue and Market Share by Manufacturer
8.5 Canada Transdermal Drug Delivery System Export and Import (2012-2017)
9 Mexico Transdermal Drug Delivery System Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Transdermal Drug Delivery System Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Transdermal Drug Delivery System Sales and Market Share by Type
9.3 Mexico Transdermal Drug Delivery System Sales by Application (2012-2017)
9.4 Mexico Transdermal Drug Delivery System Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Transdermal Drug Delivery System Sales and Market Share by Manufacturer
9.4.2 Mexico Transdermal Drug Delivery System Revenue and Market Share by Manufacturer
9.5 Mexico Transdermal Drug Delivery System Export and Import (2012-2017)
10 Transdermal Drug Delivery System Market Forecast (2017-2022)
10.1 North America Transdermal Drug Delivery System Sales, Revenue and Growth Rate (2017-2022)
10.2 Transdermal Drug Delivery System Market Forecast by Countries (2017-2022)
10.2.1 United States Transdermal Drug Delivery System Forecast (2017-2022)
10.2.2 Canada Transdermal Drug Delivery System Forecast (2017-2022)
10.2.3 Mexico Transdermal Drug Delivery System Forecast (2017-2022)
10.3 Transdermal Drug Delivery System Market Forecast by Type (2017-2022)
10.4 Transdermal Drug Delivery System Market Forecast by Application (2017-2022)
11 Transdermal Drug Delivery System Manufacturing Cost Analysis
11.1 Transdermal Drug Delivery System Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Transdermal Drug Delivery System
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Transdermal Drug Delivery System Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 34220

Category: 11

Published date: 2017-10-04 19:13:01

Number of Pages: 123

Publisher Name: GIR

Over all Rating: 86 % (Average of Ratings provided by clients)